CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Girshick Birgit Corporate Executive VP & COO | Shares withheld for taxes | −1,025 | $165.57 | $170K | 53,544 |
| 2024-11-08 | FOSTER JAMES C Chairman, President and CEO | Gift | −4,500 | 184,783 | ||
| 2024-11-07 | WALLMAN RICHARD F Director | Sale | −3,371 | $215.75 | $727K | 15,636 |
| 2024-11-07 | WALLMAN RICHARD F Director | Sale | −3,250 | $216.50 | $704K | 12,386 |
| 2024-11-07 | WALLMAN RICHARD F Director | Sale | −1,000 | $216.50 | $217K | 0 |
| 2024-11-07 | Barbo William D Corporate Executive VP & CCO | Gift | −470 | 23,337 | ||
| 2024-11-06 | WALLMAN RICHARD F Director | Gift | −4,540 | 19,007 | ||
| 2024-08-12 | FOSTER JAMES C Chairman, President and CEO | Gift | −2,500 | 185,751 | ||
| 2024-08-08 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −1,780 | $199.36 | $355K | 22,521 |
| 2024-08-01 | FOSTER JAMES C Chairman, President and CEO | Sale 10b5-1 | −25,000 | $250.00 | $6.3M | 188,251 |
| 2024-06-03 | LaPlume Joseph W EVP, Corp Strategy & Develop | Gift | −311 | 24,301 | ||
| 2024-05-31 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Grant or award | +1,727 | 8,406 | ||
| 2024-05-31 | Parisotto Shannon M CEVP, Disc & Safety Assessment | Grant or award · Stock Options (Right to Buy) | +3,925 | $208.44 | $818K | 3,925 |
| 2024-05-31 | Creamer Victoria L EVP & Chief People Officer | Grant or award | +1,967 | 14,829 | ||
| 2024-05-31 | Creamer Victoria L EVP & Chief People Officer | Grant or award · Stock Options (Right to Buy) | +4,470 | $208.44 | $932K | 4,470 |
| 2024-05-31 | Girshick Birgit Corporate Executive VP & COO | Grant or award | +3,838 | 50,512 | ||
| 2024-05-31 | Girshick Birgit Corporate Executive VP & COO | Grant or award · Stock Options (Right to Buy) | +8,722 | $208.44 | $1.8M | 8,722 |
| 2024-05-31 | FOSTER JAMES C Chairman, President and CEO | Grant or award · Stock Options (Right to Buy) | +24,858 | $208.44 | $5.2M | 24,858 |
| 2024-05-31 | Pease Flavia Corporate Executive VP & CFO | Grant or award | +2,159 | 9,760 | ||
| 2024-05-31 | Pease Flavia Corporate Executive VP & CFO | Grant or award · Stock Options (Right to Buy) | +4,906 | $208.44 | $1.0M | 4,906 |
Page 12 of 33 · 654 trades